The U.S. Food and Drug Administration continues its public workshop at 9 a.m. ET on July 16 on the development of antihypertensive therapies for pediatric patients. The second day focuses on advancing treatment strategies and generating evidence for the safe and effective use of blood pressure medications in children, including those under 6 years old.
…Â
FDA Workshop Focuses on Pediatric Hypertension Treatments (DAY 2)
